It was recently demonstrated that LUM/IVA therapy leads to a partial rescue of CFTR function of about 10% to 20%, which is comparable to the lower range of CFTR function in patients with CF and residual function mutations [34]. This evidence concerns the gene CFTR and cystic fibrosis.